The current valuation score of Roivant Sciences Ltd is 9.36, ranking 25 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -72.75, which is -102.91% below the recent high of 2.11 and -3.12% above the recent low of -75.02.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.